The Future of Personalized Wellness
Zephyr – A Natural Approach to Health
Supporting health and longevity with cutting-edge biotech innovations and natural products.
Our Focus
Dedicated to revolutionizing healthspan through research in the fields of diabetes, obesity, skincare, and mental health. Our innovative approach combines cutting-edge biotechnology with natural remedies to provide effective solutions for these critical health areas.
Diabetes Management
Developing natural compounds that significantly support healthy blood sugar levels by offering a safer alternative to existing medications.
Weight Management
Natural compounds designed to support healthy weight loss without pharmaceutical interventions.
Advanced Skincare
Solutions that address the challenges of rapid weight loss, offering treatments that enhance skin elasticity and reduce the appearance of wrinkles.
Innovative Solutions for a Healthier You
Biotech Meets Nature
Zephyr uniquely integrates biotechnology with natural compounds to create groundbreaking health solutions.
Precision Medicine
Zephyr is using advanced DNA and biomarker analysis to meet individual health needs.
Sustainable Wellness
Our commitment to sustainability ensures our products support both personal health and environmental wellness.
Cutting-Edge Research
Leveraging AI and machine learning, we innovate new drug targets and therapeutic strategies for better health outcomes.
Our Mission to Enhance Healthspan
Zephyr Group is developing ways to help people live healthier for more years, not just live longer.
Combining modern science with natural ingredients to make health and wellness products.
Focusing on big health issues like diabetes, weight management, skin health, and mental wellness.
Utilizing technologies like AI and DNA testing, Zephyr aims to create treatments that are personalized for each person.
We care about sustainability, so the goal is to help people — and the planet — stay healthier.
Lead by a world-class team of scientists, clinicians and business experts, our group is accelerating the commercialization of cutting-edge wellness technologies that bridge the gap between biotech innovation and consumer health.
Pioneering Innovation
Zephyr is pioneering a proprietary health-tech ecosystem that merges AI-driven informatics with epigenetic data to deliver hyper-personalized wellness. By synthesizing DNA and biomarker analysis, we are transforming precision medicine into a scalable, consumer-facing platform that optimizes health outcomes at the individual level.
Discover the Future of Healthspan
Discover how Zephyr is bridging the gap between clinical biotechnology and botanical innovation. Our proprietary product pipeline leverages the synergy of peptide-phytoceutical science to unlock peak biological performance and long-term vitality.
Discover the Future of Healthspan
Own the Future of Longevity with Zephyr
Join us as we disrupt the multi-trillion dollar wellness industry through a proprietary fusion of clinical biotechnology and bioactive botanical innovation. Invest in a platform-driven approach to enhancing healthspan and help us scale the next generation of precision wellness solutions.
Innovative Solutions
Biotech Meets Nature
Healthspan Revolution
Invest in Wellness
Pioneering Personalized Health Solutions
Revolutionizing Wellness with Biotechnology
“A healthier future through clinical innovation. We are commercializing a robust pipeline of biotech-backed solutions designed to optimize healthspan and disrupt the $5.6 trillion global wellness industry.”
Innovative Biotechnology
Our Cutting-Edge Initiatives
AI-Driven Drug Discovery
Utilizing artificial intelligence to identify novel drug targets and enhance treatment effectiveness.
DNA & Epigenetic Testing
Personalizing wellness programs through comprehensive genetic and epigenetic analysis.
Precision Medicine
Tailoring treatments to individual needs for optimal health outcomes.
Sustainable Wellness Solutions
Combining biotechnology with natural compounds for eco-friendly health products.
Collaborative Research
Partnering with leading institutions to advance scientific discoveries and innovations.
Proprietary Formulations
Developing unique, patent-protected products for diabetes, obesity, and skincare.
Key Study Findings and Observed Outcomes
In an initial clinical trial, diabetic experts tested 119 type 2 diabetic patients. The aim was to test the effectiveness of our compound in balancing blood glucose, reducing hemoglobin A1c and blood lipids (cholesterol and triglycerides).
103 patients with type-2 diabetes completed a 12-week treatment and follow-up.
- Blood Glucose Values Decreased 37%
- Hemoglobin A1c Decreased 22%
- Average cholesterol Dropped 13%
- Triglycerides Dropped 40%
GLPme Formula
Boosts natural GLP-1 levels aids in restoring equilibrium to the GLP-1 slimming hormone, consequently leading to a reduction in body fat accumulation. Helps control hunger effectively and supports healthy bowel movements.
- 560-subjects preclinical study shows that subjects lost 10.8 lb in 8 weeks
- Preclinical study shows that it helps body fat reduction (averagely 2.3%)
- Support natural GLP-1 production
- Support healthy weight management
- Prebiotic + postbiotic support overall gut health
Intellectual Property:
A Defensible Innovation Moat
Strategic Patent Portfolio
Zephyr’s commercial value is anchored by a robust and growing portfolio of intellectual property. Our issued and pending patents protect a range of groundbreaking biotechnological advancements, providing a high-barrier-to-entry “moat” and ensuring a sustained competitive advantage within the global health and longevity sectors.
Proprietary Multi-Target Formulations
Our proprietary compounds represent the next generation of precision wellness. By synthesizing high-efficacy clinical science with bioactive botanical isolates, we have developed unique, patent-protected solutions targeting high-growth therapeutic areas: Metabolic Health (Diabetes & Obesity) and Advanced Dermatological Science (Skincare).
Clinical Biotech Advancements
Zephyr’s R&D engine is fueled by extensive laboratory research and data-driven development. Our focus on peptide-phytoceutical synergies has led to the discovery of novel therapeutic compounds that bridge the gap between traditional medicine and preventative wellness.
Exclusive Commercial Rights
We maintain strict, exclusive control over our intellectual property assets. This proactive safeguarding of our innovations not only protects our current pipeline but also provides the foundational stability required for rapid global scaling and long-term institutional value.
Untapped Market Opportunity
Endocannabinoid System
Research suggests that modulating the ECS could potentially slow down the aging process and improve healthspan
As we age, the ECS undergoes changes, and its function can decline. This decline has been linked to various age-related diseases, including neurodegenerative disorders, cardiovascular disease, and metabolic syndrome.
It’s a fascinating area of research with significant implications. Zephyr researchers believe that by understanding the role of the ECS in aging and disease, that we can develop innovative strategies to improve human healthspan and longevity.
The relationship between diabetes and the ECS is a complex and fascinating area of research with significant implications for potential therapeutic interventions.
Forging Unbreakable Alliances
Strategic Infrastructure: Scaling Through High-Impact Alliances
Accelerating Biotech Innovation via Global Collaboration
At Zephyr, we recognize that the future of longevity isn’t built in isolation. Our growth is anchored by a robust ecosystem of strategic partnerships—integrating the academic rigor of leading universities, the specialized capabilities of pharmaceutical leaders, and the precision of world-class manufacturing experts. These alliances form the bedrock of our mission to globalize advanced healthspan solutions.
The Challenge: The Institutional Gatekeeper
Traditional venture capital models often “silo” the most transformative healthcare breakthroughs, restricting access and ownership to a select few. This legacy approach creates a bottleneck for innovation and excludes the very people these products are meant to serve.
The Zephyr Mission: Democratizing Discovery
Zephyr Group is a science-driven, purpose-led platform designed for inclusivity. We synthesize rigorous clinical biotechnology with bioactive botanical compounds to deliver scalable, high-efficacy longevity solutions. We aren’t just building products; we are building a more accessible frontier of human health.
The Investment: Aligning Progress with Purpose
We are raising capital through our community because we believe those who benefit from innovation should have the opportunity to own it. By investing in Zephyr, you are participating in a shift toward meaningful, decentralized progress. We invite you to invest alongside us and co-own the future of longevity.
Commercial Strategy: High-Growth Revenue Verticals
Precision Supplementation & Metabolic Health
Zephyr’s core supplement line leverages proprietary biotechnology to deliver high-efficacy health solutions. By targeting critical biomarkers in metabolic health and cellular aging, we are capturing a significant share of the rapidly expanding longevity market.
Advanced Dermatological Science (Skincare)
Our skincare portfolio is engineered with bio-identical peptides and high-potency botanical isolates. This clinical-grade approach addresses the root causes of skin degradation and cellular rejuvenation, positioning Zephyr at the intersection of luxury wellness and dermatological biotechnology.
Personalized Therapeutic Pipeline
Zephyr is pioneering a new class of interventions that integrate precision medicine with bioactive compounds. These data-driven, personalized health protocols represent a high-value vertical designed to disrupt traditional reactive healthcare models with proactive, individualized solutions.
Holistic Healthspan Ecosystem
Beyond individual products, Zephyr provides an integrated suite of holistic health solutions. This ecosystem is designed to enhance total well-being and drive long-term customer lifetime value (LTV) by supporting sustained healthspan through a recurring revenue model.
Meet Our Expert Leadership Team
D. Roy Serventi
Founder and CEO
Jerry Washburn
Vice President and CFO
Dr. David Lorrabaquio Sanchez, MD
Interim Chief Medical Director
Dr. Jeanette Jacknin, MD
Sr. Medical Advisor
Dr. Zoraida P. Aguilar, PhD, MS
Interim Chief Science Officer
Dr. Luis David Suárez Rodríguez, MD
Sr. Medical Advisor
Kevin Stock
Director of Integration & Brand Development
Judith S. Reyes
V.P. of Business Development and Operations
Hector Perez, MSOM
Director of Nutraceutical Formulation and Wellness Education
Enrique Rodriguez Macias, PhD.
General Manager of Mexico Business Development
Max Serventi
Logistics & Digital Marketing Manager
Nicholas Serventi
Financial Advisor
Pierre Sayad, PhD., M.S.
Senior Advisor
Dr. Jaiprakash (Jai) Shewale, PhD
Senior Advisor
Amanda Vega
Senior Advisor
Sean Kelley
Senior Advisor
Victoria Schwartz
Senior Advisor
Secure Your Stake in the Longevity Revolution
The Future of Biotech is Personal. Own a Piece of It.
Zephyr is at the intersection of a massive market shift—where clinical biotechnology meets consumer wellness. With our defensible IP moat, a validated product pipeline, and a scalable data-driven platform, we are positioned to disrupt the $5.6 trillion global wellness economy.
This is more than an investment in health; it is an investment in the infrastructure of human longevity. We invite you to join our Series Seed raise and align your portfolio with the next frontier of medical innovation.
View Offering Circular & Terms